ATE223722T1 - Verfahren zur herstellung von efonidipinhaltigen arzneimitteln - Google Patents
Verfahren zur herstellung von efonidipinhaltigen arzneimittelnInfo
- Publication number
- ATE223722T1 ATE223722T1 AT97907336T AT97907336T ATE223722T1 AT E223722 T1 ATE223722 T1 AT E223722T1 AT 97907336 T AT97907336 T AT 97907336T AT 97907336 T AT97907336 T AT 97907336T AT E223722 T1 ATE223722 T1 AT E223722T1
- Authority
- AT
- Austria
- Prior art keywords
- treatment
- mixture
- water
- efonidipine
- efonidipine hydrochloride
- Prior art date
Links
- NSVFSAJIGAJDMR-UHFFFAOYSA-N 2-[benzyl(phenyl)amino]ethyl 5-(5,5-dimethyl-2-oxido-1,3,2-dioxaphosphinan-2-yl)-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3-carboxylate Chemical compound CC=1NC(C)=C(C(=O)OCCN(CC=2C=CC=CC=2)C=2C=CC=CC=2)C(C=2C=C(C=CC=2)[N+]([O-])=O)C=1P1(=O)OCC(C)(C)CO1 NSVFSAJIGAJDMR-UHFFFAOYSA-N 0.000 title abstract 4
- 229950003102 efonidipine Drugs 0.000 title abstract 4
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 229940126601 medicinal product Drugs 0.000 title 1
- 239000000203 mixture Substances 0.000 abstract 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 3
- 238000010438 heat treatment Methods 0.000 abstract 2
- 230000000968 intestinal effect Effects 0.000 abstract 2
- 239000007962 solid dispersion Substances 0.000 abstract 2
- 238000007598 dipping method Methods 0.000 abstract 1
- 229920000639 hydroxypropylmethylcellulose acetate succinate Polymers 0.000 abstract 1
- 238000005470 impregnation Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000003960 organic solvent Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
Landscapes
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP8886896 | 1996-03-18 | ||
| JP8886996 | 1996-03-18 | ||
| PCT/JP1997/000842 WO1997034610A1 (en) | 1996-03-18 | 1997-03-17 | Process for producing efonidipine hydrochloride preparations |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE223722T1 true ATE223722T1 (de) | 2002-09-15 |
Family
ID=26430207
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT97907336T ATE223722T1 (de) | 1996-03-18 | 1997-03-17 | Verfahren zur herstellung von efonidipinhaltigen arzneimitteln |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US6171599B1 (de) |
| EP (1) | EP0893999B8 (de) |
| KR (1) | KR100457273B1 (de) |
| AT (1) | ATE223722T1 (de) |
| AU (1) | AU1941897A (de) |
| CA (1) | CA2248582C (de) |
| DE (1) | DE69715395T2 (de) |
| ES (1) | ES2184063T3 (de) |
| PT (1) | PT893999E (de) |
| TW (1) | TW487574B (de) |
| WO (1) | WO1997034610A1 (de) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK0901786T3 (da) | 1997-08-11 | 2007-10-08 | Pfizer Prod Inc | Faste farmaceutiske dispersioner med foröget biotilgængelighed |
| CN1630629B (zh) * | 2002-02-28 | 2010-05-05 | 日本烟草产业株式会社 | 酯化合物及其医药用途 |
| JP4832897B2 (ja) * | 2003-08-29 | 2011-12-07 | 日本たばこ産業株式会社 | エステル誘導体及びその医薬用途 |
| US20060030623A1 (en) * | 2004-07-16 | 2006-02-09 | Noboru Furukawa | Agent for the treatment or prevention of diabetes, obesity or arteriosclerosis |
| DE602005018387D1 (de) * | 2004-10-06 | 2010-01-28 | Eisai R&D Man Co Ltd | Medizinische zusammensetzung, verfahren zu ihrer hdihydropyridin-verbindung in einer medizinischen zusammensetzung |
| US8101774B2 (en) * | 2004-10-18 | 2012-01-24 | Japan Tobacco Inc. | Ester derivatives and medicinal use thereof |
| BRPI0516772A (pt) * | 2004-10-25 | 2008-09-23 | Japan Tobacco Inc | formulação sólida com solubilidade e estabilidade melhoradas e método para produção da referida formulação |
| US20100016378A1 (en) * | 2005-04-28 | 2010-01-21 | Toshio Suzuki | Method of preventing dihydropyridine compound from degradation |
| JPWO2007108463A1 (ja) | 2006-03-23 | 2009-08-06 | 塩野義製薬株式会社 | 溶解性が改善された固形製剤 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1016063B (zh) * | 1986-01-22 | 1992-04-01 | 日产化学工业株式会社 | 二氢吡啶-5-膦酸环亚丙基酯的制备 |
| JP2528706B2 (ja) | 1988-05-30 | 1996-08-28 | ゼリア新薬工業株式会社 | ジヒドロピリジン化合物の製剤組成物 |
-
1997
- 1997-03-17 KR KR10-1998-0707339A patent/KR100457273B1/ko not_active Expired - Fee Related
- 1997-03-17 EP EP97907336A patent/EP0893999B8/de not_active Expired - Lifetime
- 1997-03-17 TW TW086103291A patent/TW487574B/zh not_active IP Right Cessation
- 1997-03-17 DE DE69715395T patent/DE69715395T2/de not_active Expired - Fee Related
- 1997-03-17 PT PT97907336T patent/PT893999E/pt unknown
- 1997-03-17 ES ES97907336T patent/ES2184063T3/es not_active Expired - Lifetime
- 1997-03-17 AT AT97907336T patent/ATE223722T1/de not_active IP Right Cessation
- 1997-03-17 WO PCT/JP1997/000842 patent/WO1997034610A1/en not_active Ceased
- 1997-03-17 CA CA002248582A patent/CA2248582C/en not_active Expired - Fee Related
- 1997-03-17 US US09/142,208 patent/US6171599B1/en not_active Expired - Fee Related
- 1997-03-17 AU AU19418/97A patent/AU1941897A/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| PT893999E (pt) | 2002-12-31 |
| WO1997034610A1 (en) | 1997-09-25 |
| AU1941897A (en) | 1997-10-10 |
| TW487574B (en) | 2002-05-21 |
| CA2248582C (en) | 2005-06-14 |
| ES2184063T3 (es) | 2003-04-01 |
| US6171599B1 (en) | 2001-01-09 |
| KR20000064632A (ko) | 2000-11-06 |
| EP0893999B1 (de) | 2002-09-11 |
| EP0893999B8 (de) | 2003-01-02 |
| DE69715395D1 (de) | 2002-10-17 |
| CA2248582A1 (en) | 1997-09-25 |
| EP0893999A1 (de) | 1999-02-03 |
| KR100457273B1 (ko) | 2005-04-08 |
| DE69715395T2 (de) | 2003-05-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69600622D1 (de) | Bilden von lösungen von cellulose in wässrigem tertiärem aminoxid | |
| ATE232210T1 (de) | Verfahren zur herstellung von erythromicin a-oxim | |
| DE69715395D1 (de) | Verfahren zur herstellung von efonidipinhaltigen arzneimitteln | |
| DE3773210D1 (de) | Verfahren zur herstellung eines aktivkohlekatalysators. | |
| SU604462A3 (ru) | Способ стерилизации упаковочного материала | |
| FI971932A0 (fi) | Menetelmä pesu- ja puhdistusainetablettien valmistamiseksi mikroaalto- ja kuumailmakäsittelyllä | |
| JPS51142482A (en) | A process and apparatus for treatment of putrefactive wastes | |
| MY110907A (en) | Method and apparatus for treating wood material and porous inorganic material | |
| KR0128105B1 (ko) | 홍삼제조방법 | |
| ATE246982T1 (de) | Vorrichtung und verfahren zum behandeln von kunststoffmaterial | |
| JPS5515622A (en) | Exhaust gas pretreating method | |
| JPS5424457A (en) | Process for swelling treatment of organic sludge | |
| HU904060D0 (en) | Process for decomposing soap by means of high-temperature treating | |
| DE69600958D1 (de) | Verfahren zur Herstellung von 1-Beta-D-Arabinofuranosylcytosine | |
| KR950011928B1 (ko) | 사문석을 주제로한 흡착제 제조방법 | |
| ATE128327T1 (de) | Verfahren zur herstellung von getrocknetem kollagen. | |
| KR970033018A (ko) | 코크스공장의 부산물을 이용한 흡착제 제조방법 | |
| GB1027978A (en) | Gelatine degradation produces and a process for producing them | |
| NL7601042A (nl) | Werkwijze en inrichting voor de warmte- en druk- behandeling van materiaal, bijvoorbeeld voedings- middelen, evenals voedingsmiddelen behandeld vol- gens de werkwijze. | |
| DE68900524D1 (de) | Verfahren zur herstellung von benzylmerkaptan. | |
| ATA373478A (de) | Plattenfoermiges bauelement sowie vorrichtung und verfahren zudessen herstellung | |
| KR890001464A (ko) | 제라틴을 이용한 건포류의 연질화 방법 | |
| ES479963A1 (es) | Procedimiento de tratamiento de productos lenosos fragmenta-dos y secos. | |
| JPS61199798A (ja) | カルサミンの製造方法 | |
| SE9804024L (sv) | Förfarande för behandling av svartlut |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |